Hossein Tavana

Dr. Hossein Tavana is a Professor and Department Chair in the College of Engineering and Polymer Science at the University of Akron, Ohio. He joined the university in 2010 and leads the Biomedical Engineering department, focusing on tissue engineering microtechnologies to mimic cellular microenvironments. His research spans 3D tumor models for studying cancer drug resistance, lung airway models for therapeutic delivery studies, and biofluid mechanics.

• Education:
  • Ph.D. in Mechanical Engineering, University of Toronto (2006)
  • M.A.Sc. in Mechanical Engineering, K.N. Toosi University of Technology (1999)
  • B.Sc. in Mechanical Engineering, Tabriz University (1996)

Research Interests: Dr. Tavana’s work lies at the intersection of Cancer Research, Microtechnology, and Tissue Engineering. He develops 3D tumor models to study drug resistance mechanisms and lung airway models to optimize therapeutic delivery. His projects combine experimental and computational approaches and involve collaborations with engineers, medical professionals, and clinical researchers.

Article Trends: His publications emphasize 3D cell culture, microfluidic devices, and drug screening technologies. Topics include surfactant transport in lungs, kinase inhibition in cancer cells, and tumor-stromal interactions. Most works involve interdisciplinary methodologies and biomedical applications of engineering principles.

Scientific Awards:

• BMES' Young Innovator in Cellular and Molecular Bioengineering
• Top 20 Young Investigator Frontiers in Bioengineering
• Prestigious postdoctoral fellowship at the University of Michigan's Biomedical Engineering Department

Grants & Patents: He has secured 10 grants from the NIH and NSF to fund his interdisciplinary projects. He holds 6 patents in biomedical engineering technologies and has published 70 peer-reviewed papers.

Labs & Teams: Dr. Tavana’s lab is based in Olson Research Center 301F (Lab Olson 311-313) at the University of Akron. His team collaborates with engineering, medical, and clinical investigators on projects funded by NIH, NSF, and DoD.